Form D · Biotechnology
Costanoan Biotechnologies Inc.
Portland, OR · CIK 0001691297
Offering snapshot reported Jan 5, 2017 · SEC filing
- Reported sold
- $69.6K Offering amount: $248K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 15, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 5, 2017 | Initial | $69,631 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 04
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-277708
Source: Form D, filed Jan 5, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tracy Thompson | Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4640 Sw Macadam Ave. Suite 130
Portland, OR, 97239
Portland, OR, 97239